Design
A randomised, parallel group, feasibility trial with blinded outcome assessment at end of the intervention.
Study setting
Adolescents (N = 30; 13–17 years both inclusive) with recurrent nonsuicidal self-injury referred to outpatient clinics in Child and Adolescent Mental Health Services (CAMHS) in the Capital Region of Denmark. We wish to include a pragmatic population of patients with a variety of diagnoses since all may present with comorbidity of NSSI.
Eligibility criteria
-
≥ 5 non-suicidal self-injury episodes during the past year and ≥ 1 non-suicidal self-injury episodes during the past month assessed by the Deliberate Self-Harm Inventory, Youth version (DSHI-Y) (35).
-
Age-appropriate Danish literacy assessed by referring clinicians and the self-injury team.
-
At least one parent committing to participate in the parent program.
-
Informed consent from parents/legal caretakers.
-
Informed consent from the participant above 15 years of age.
Exclusion criteria
-
Elevated or imminent suicidal risk assessed by clinicians during routine screening procedure (that can be rated as no risk, elevated risk, or imminent risk) in need of admission or other life saving strategies.
-
Lack of informed consent from parents/legal caretakers.
-
Lack of informed consent from the participant above 15 years of age.
Informed consent for trial participation
Detailed trial description and informed consent forms will be sent electronically to eligible participants and their parents linking personal id numbers to secure mailbox. During the baseline interview after further assessment of eligibility, the clinicians will ask participants (adolescents > 15 years of age and both custody holders) to give informed consent by accessing this secure link and sign. These will be stored directly in the research database, REDCap.
Treatment as usual
Both the experimental group and the control group will receive TAU in CAMHS. TAU encounters a variety of clinical treatment and assessment offers, representing a highly inhomogeneous group of treatments, for instance: pharmacological treatment, family-based treatment, cognitive behavioural therapy, supportive counselling, and psychoeducation. Throughout the trial, the treatment responsibility is handled by clinicians providing TAU in CAMHS. TAU will be delivered equally in both intervention groups and documented, including patient safety screening and planning. Routinely screening for suicidal behaviour is a part of the standard clinical assessment and treatment in CAMHS.
ERITA
The ERITA intervention (33, 34) as add-on to TAU is a manualised internet-based therapy based on emotion regulation group therapy, cognitive behavioural therapy, dialectical behavioural therapy, and acceptance and commitment therapy. The program consists of an introduction plus 11 modules ranging in content from psychoeducation, through emotional awareness training, and regulation of impulses and emotions by acceptance and validation (Table 1). The intervention also provides six modules for the parents focusing on NSSI and other risk-taking behaviours, emotional awareness, and validation skills (Table 1).
Table 1
An overview of the content of internet based ERITA
Adolescent intervention (module content) | Parent program (module content) |
(1) Functions of non-suicidal self-injury | (1) Psychoeducation |
(2) Impulse control | |
(3) Functionality of emotions and emotional awareness | (2) Emotional awareness |
(4) Primary vs. secondary emotions | |
(5) Emotional avoidance / unwillingness vs. emotional acceptance / willingness | (3) Validation and invalidation |
(6) Non-avoidant emotion regulation strategies | |
(7) Implementing emotional approach and non-avoidant emotion regulation strategies | (4) Self-validation and self-invalidation |
(8) Validation and emotional approach | |
(9) Valued direction | (5) How to improve parenting in the long run / behavioral activation |
(10) Repetition | |
(11) Relapse prevention | (6) Summary and evaluation |
ERITA is provided online and therapist guided. The participants are expected to complete one module every week while the parents are expected to complete a module every second week. A mobile app is available to complement the online treatment. The app includes reminders of homework and skills and allows to report on both self-destructive behaviours and impulses daily. Weekly, electronically assessments of emotion regulation skills, NSSI, and potential risk behaviours will serve as intervention indicators for the therapist to guide the young ERITA participant during the intervention process. This intervention also includes a parent program with six modules focusing on psychoeducation and validations skills. The parents can review the adolescents’ chapters each week, but not the correspondence between the adolescents and the therapist. In contrary to previous evaluations of ERITA (33, 34), the parent part of ERITA is not therapist guided in the current trial.
Table 1: An overview of the content of internet-based ERITA
Strategy to improve adherence to intervention
If a participant fails to follow the treatment course by not accessing the web portal or by not replying to therapists’ messages, the intervention team will assertively reach out by phone to both the patient and the parents. It is expected that major parts of the dialogue with participants constitute motivation to adhere to the ERITA.
Staff, qualification, and training
The staff in the self-injury team consists of psychologists and nurses, recruited with priority on experience within clinical child and adolescent psychiatry and with psychotherapy and special knowledge about NSSI. The staff is trained in the ERITA-manual (32) and will continually be supervised in the internet-based methods by clinicians and researchers of the Swedish National Self-Injury Project alongside Danish experts in the field. The self-injury team will warrant for the recruitment strategy by a continuous dialogue and update of staff in CAMHS.
Outcomes
Feasibility outcomes are listed in order of importance
1. Completion of follow-up
Completion of follow-up will be defined as completing assessment of at least one clinical outcome (NSSI events) at end of intervention. If the number participants with completed outcomes is 26 out of 30, the fraction will be 87%, 95% confidence interval (CI) 75–99%. A follow-up fraction of 75% or more will be acceptable for a future trial while a fraction below 75% will impose serious problems of interpreting the trial result in a future large pragmatic trial.
2. The fraction of participants assessed for eligibility who consent to inclusion and randomisation
We will determine the fraction of potential participants as the number of eligible persons compared to the number of randomised persons. If the number of participants randomised out of the number of eligible persons is 30 out of 75, the fraction will be 40%, 95% CI 29–51%. A randomisation fraction of 29% or more will be acceptable for a future trial, while a fraction below 29% will impose serious problems of recruitment for a future large pragmatic trial.
3. Compliance - Adolescents
Compliance with the experimental intervention will be defined as completing at least 6/12 ERITA sessions. The treatment platform will automatically register time for login and save the exercises that have been completed. If the number of compliant experimental participants is 11 out of 15, the fraction will be 73%, 95% CI 51–96%. A compliance fraction of 51% or more will be acceptable for a future trial while a fraction below 51% will impose serious problems of interpreting the trial result in a future large pragmatic trial.
4. Compliance - Parents
Compliance with the experimental intervention will be defined as completing at least 3/6 ERITA sessions. The treatment platform will automatically register time for login and save the exercises that have been completed. If the number of compliant experimental participants is 11 out of 15, the fraction will be 73%, 95% CI 51–96%. A compliance fraction of 51% or more will be acceptable for a future trial while a fraction below 51% will impose serious problems of interpreting the trial result in a future large pragmatic trial.
Clinical outcomes
We will assess participants at the baseline interview and at the end of the intervention at 12 weeks after randomisation. The clinical outcomes are planned for a future pragmatic randomised trial, and these will only be investigated in an exploratory manner in this feasibility trial.
Explorative primary clinical outcome
Explorative secondary clinical outcomes
-
Quality of life at 12 weeks, assessed with Health-Related Quality of Life Questionnaire ( Kidscreen-10) (36).
-
Symptoms of depression, anxiety, and stress at 12 weeks, assessed with Depression Anxiety Stress Scale (DASS-21) (37).
-
Number of sick days the last month, assessed at 12 weeks.
Further explorative clinical outcomes
-
The proportion of participants with no NSSI during the last four weeks, assessed at 12 weeks follow-up (end of intervention).
-
Difficulties in emotion regulation, assessed weekly during 12 weeks with Difficulties in Emotion Regulation Scale – 16 Item Version (DERS-16) (38).
-
Indirect self-destructive behaviours at 12 weeks, assessed with Borderline Symptom List (BSL-supplement) (39).
-
Suicidal ideations, plans, and actions at 12 weeks, assessed with Columbia Suicide Rating Scale (C-SSRS) (40).
-
Adolescent rated parents' ability to cope with children's negative emotions at 6 weeks and 12 weeks, assessed with The Coping with Children’s Negative Emotions Scale (CCNES-APP) (41).
-
Parent-rated perceived ability to cope with children's negative emotions at 6 weeks and 12 weeks, assessed with The Coping with Children's Negative Emotions Scale Adolescent (CCNES-A) (41).
-
Adverse Events of therapy at 12 weeks assessed with Negative Effects Questionnaire (NEQ) (42).
-
Strengths and difficulties assessed by Strengths and difficulties questionnaire (SDQ) assessed at end of intervention (43).
-
Working alliance with online therapist at 4 and 8 weeks, assessed with Working Alliance Inventory, short version (WAI-SR) (44).
Participant safety
TAU
Throughout the trial the treatment responsibility is handled by clinicians providing TAU, including continuous risk assessment of suicidal behavior as a part of routine clinical procedures and documentation. Patients receiving treatment in CAMHS and their families are instructed to attend the Child and Adolescent Mental Health Services emergency department in case of imminent suicidal risk. All families are carefully instructed on safety routines within the trial; hence it is firmly stated in the participants’ instructions that therapists are only available during working hours. In case of imminent risk and no contact can be made, the intervention team will notify the clinical staff providing TAU and hereby ensure further acute clinical psychiatric assessment.
ERITA
As a part of the provision of ERITA participants in the experimental arm will weekly fill out electronic questionnaires on emotion regulation and potential risk behavior such as alcohol drinking or substance misuse as well as suicidal behavior. The weekly assessments serve two purposes: firstly, to provide the ERITA therapists with data on NSSI and emotion regulation skills as a part of the provision of the intervention. Secondly, since internet-based interventions have not previously been applied in CAMHS these weekly assessments ensure participant safety and facilitate detection of sudden deterioration of participants, including suicidal ideation. An individualised crisis plan will be established prior to treatment start, which will contain necessary contact information to acute health care services. If the patient during the research course is assessed to be at increased suicidal risk, a notification in the program will alert all team members and a therapist will contact both the patient and the parents next working day.
Diagnostic assessments and outcome measures
Patient record data
Both the baseline and 12 weeks follow-up interviews are held virtually in secure meeting fora. Data obtained manually during the interviews are entered in an electronic research data base right after the interviews. None of the interviews are audio or video taped. The baseline interview is scheduled to take 2.5 hours while the follow-up interview will take about 30 minutes. To minimise the baseline interview and assessment program, diagnosis codes will be obtained from patient records as a part of general clinical procedures. Also, data on the provision of TAU (treatment and length) for all participants will be obtained from the patients records by the end of treatment (12 weeks). Information on explorative outcomes and sick days the last four weeks will be obtained as self-reported at both baseline and follow-up by electronic questionnaires.
Figure 1, Participant timeline
Intervention data
During the internet-based intervention, data in the form of text as a part of the therapy will be provided; homework assignments will be presented, and therapists will write and interact with the participants, accordingly. The correspondence and interaction with participants and parents will differ in content according to individual needs but is expected to contain information on issues related to self-injury and coping strategies. Resource monitoring: we expect much of the therapeutic effort to focus on motivation to comply with modules and homework assignments. However, we do not yet know to what extent additional contact or support such as telephone calls or additional initiatives (e.g. emergency interventions) are required by the self-injury team.
Technical issues
A systematic monitoring of technical obstacles will be applied: login failures, forgotten passwords, inability to proceed during assignments or tasks, inability to hear audios or videos, and other unforeseen issues. All platform appearance will be monitored in detail including the need for web support. If technical issues appear or implementation as well as completion of the online intervention (misunderstanding of modules or assignments) then adjustments will be considered in dialogue with the developers to ensure the internal validity in future large-scale trials.
Resource allocation
A systematic monitoring of additional resources such as crisis phone calls, calls to treatment provider in TAU, parents’ consultations or rescheduling of baseline appointments will take place.
Sample size and power considerations
In this feasibility trial, we will include 30 participants corresponding to less than 10% of the probable sample size needed in a pragmatic large-scale trial. This corresponds to a power of 18% for the primary clinical outcome (self-injury episodes) in this trial, indicating that any positive result is purely exploratory and could be due to random error.
Analysis, randomisation, and blinding
The randomisation procedure will be provided by The Copenhagen Trial Unit (CTU) and be web-based. The allocation sequence will be computer-generated using block sizes of varying length concealed for the investigators. The allocation ratio is 1:1 and is blinded to the investigators.
Baseline characteristics will be assessed using descriptive statistics. The clinical exploratory outcomes will be analysed according to the principle of an intention-to-treat approach. In a subsequent large-scale trial, missing data will be accounted for by multiple imputations if data are missing at random. All data on participants will be analysed independently of adherence to treatment. We will analyse data using logistic regression for dichotomous outcomes and linear regression for continuous outcomes. Due to the nature of the intervention, a blinding of participants and therapists is not possible. Blinded outcome assessment will be performed. Statistical analyses will be performed by two blinded statisticians presenting independent reports. Based on the two blinded conclusions, two abstracts will be written and published (on a website).